AdvertiseDonate
New YorkJersey CityNewarkBostonPhiladelphiaBaltimoreWashingtonBuffalo
Tuesday, November 17, 2026Headlines from coast to coast.
Newz Analysis · 157 Church Street, 19th floor, New Haven, CT 06510

Isomorphic Labs, founded by former DeepMind chief Demis Hassabis, raises $5 billion

The AI drug discovery startup has closed a $5 billion Series C round just months after its founder stepped down as CEO of Google DeepMind.

By News Media House Staff ·

Illustration for: Isomorphic Labs, founded by former DeepMind chief Demis Hassabis, raises $5 billion
Illustration generated for this article, not a news photograph.

Isomorphic Labs, the artificial intelligence drug discovery company founded by former Google DeepMind chief Demis Hassabis, said on Tuesday that it has raised $5 billion in a Series C funding round.

The raise comes three and a half months after Hassabis stepped back as CEO of DeepMind, Google's AI lab. He co-founded DeepMind before Google acquired it in 2014.

Greenoaks and Sequoia Capital co-led the round, joined by Andreessen Horowitz, with additional investment from Alphabet, Google's parent company. The new capital will support the design and development of new medicines built with AI.

Hassabis has served as CEO of Isomorphic Labs since the company spun out of DeepMind in 2021.

"When we founded Isomorphic, our conviction was that biology could be understood and modelled at the most fundamental molecular level and radically accelerated through AI," Hassabis said.

"This round enables us to accelerate our progress: building foundational biology models, deepening our systemic disease understanding, and driving our first therapeutic programs towards clinical trials to deliver tangible impact for patients," he added.

The company is developing a proprietary drug design engine along with a pipeline of therapeutic candidates created using AI, work it says will help deliver the next generation of medicines.

Investors have poured record sums into drug discovery startups in 2026 as the industry moves to take advantage of rapid progress in AI. According to deal-counting platform Dealroom, startups in the sector have raised $23.2 billion this year, a record figure.

Major AI labs have also pushed into the field. Anthropic announced the launch of an AI drug discovery program in June, while OpenAI partnered with Novo Nordisk in April.

Isomorphic's previous funding round came in May, when it raised a $2.1 billion Series B.

Originally published by News Media House

More News · National news · Report a business · Got a Story?

Get Newz Analysis in your inboxHeadlines from coast to coast. Free, a few times a week, unsubscribe any time.

Related stories

Latest stories

  1. UFC 2026 schedule highlights: Prochazka seeks redemption against Stirling in Qatar
  2. 21 Curated Holiday Gift Ideas for Father
  3. Chinese scientist fired after hiding death of child in gene therapy trial
  4. Hedge Fund CEO Outlines Seven Strategic Triggers for Selling Stock Positions
  5. Russian forces aim to cut off Zaporizhzhia before advancing on Dnipro, Ukrainian corps commander says
Get Newz Analysis in your inboxHeadlines from coast to coast. Free, a few times a week, unsubscribe any time.